Fat Metabolism & Lipolysis-Enhanced Research Stack
Mechanistic Synergy for Research:
- AOD-9604, a C-terminal fragment of hGH, enhances lipolysis without affecting IGF-1.
- It synergizes with Semaglutide’s appetite-regulatory and glucose-lowering effects to target adipocyte energy turnover.
Combined Benefits:
- Promotes fat oxidation and mitochondrial uncoupling via AMPK pathways.
- Amplifies caloric expenditure and insulin sensitivity when combined with Semaglutide + NAD⁺ + GSH.
Use Cases:
Non-IGF-1-based fat metabolism models, adipose inflammation research, weight regulation pathways.
